News | November 02, 2010

Next-Generation Proton Therapy System Enters Final Installation Phase

November 2, 2010 – A new proton therapy system is entering the final phase of installation at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington University School of Medicine in St. Louis, Mo.

The Monarch250, by Still River Systems, is an important treatment option for cancer patients, since it spares healthy tissue and results in fewer complications. The device houses a proton source based on the world’s first superconducting synchrocyclotron. It also provides a significant reduction in the size, cost and complexity of developing and operating a proton therapy center.

The system is installed in three phases in a radiation therapy room comparable to a conventional radiotherapy system. Phase 1 consists of rigging and mounting the accelerator gantry, which holds and positions the proton source. The second phase involves assembling and installing the clinical environment. The third and final phase consists of the installation of the accelerator module.

Bill Alvord, the institution’s vice president of operations, said the first and second phases take about two months to complete.

The production accelerator is now undergoing clinical commissioning, and all clinical parameters have exceeded performance expectations.

Still River Systems will be exhibiting at the American Society for Radiation Oncology (ASTRO) conference in San Diego, Calif. The Monarch250 has not been cleared by the U.S. Food and Drug Administration (FDA).

For more information: www.stillriversystems.com

Related Content

Sponsored Content | Videos | Radiation Oncology | November 30, 2018
Accuray's philosophy is to personalize treatments to exactly fit the patient.
Ohio State University to Open Region’s First Proton Therapy Facility

Image courtesy of The Ohio State University James Comprehensive Cancer Center

News | Proton Therapy | November 21, 2018
The Ohio State University Wexner Medical Center and the Arthur G. James Cancer Hospital and Richard J. Solove Research...
Videos | ASTRO | November 08, 2018
ITN Editor Dave Fornell took a tour of some of the most innovative technologies on display on the expo floor at the 
The Fujifilm FCT Embrace CT System displayed for the first time at ASTRO 2018.
360 Photos | 360 View Photos | November 07, 2018
Fujifilm's first FDA-cleared compu...
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for radiation therapy displayed for the first time since gaining FDA clearance in 2018. It was displayed at the American Society for Radiotherapy and Oncology (ASTRO) 2018 annual meeting. Read more about this system at ASTRO 2018. #ASTRO18 #ASTRO2018
360 Photos | 360 View Photos | November 07, 2018
This is the Siemens Magnetom Sola RT edition 1.5T MRI system optimized for...
GE Healthcare Discovery RF Gen 2 system displayed at ASTRO 2018. It is a dedicated computed tomography (CT) scanner for radiation oncology
360 Photos | 360 View Photos | November 07, 2018
This is the GE Healthcare Discovery RF Gen 2 system displayed at the ...